key: cord-0975727-v7p13dh6 authors: Bailey, Adam L.; Dmytrenko, Oleksandr; Greenberg, Lina; Bredemeyer, Andrea L.; Ma, Pan; Liu, Jing; Penna, Vinay; Winkler, Emma S.; Sviben, Sanja; Brooks, Erin; Nair, Ajith P.; Heck, Kent A.; Rali, Aniket S.; Simpson, Leo; Saririan, Mehrdad; Hobohm, Dan; Stump, W. Tom; Fitzpatrick, James A.; Xie, Xuping; Zhang, Xianwen; Shi, Pei-Yong; Hinson, J. Travis; Gi, Weng-Tein; Schmidt, Constanze; Leuschner, Florian; Lin, Chieh-Yu; Diamond, Michael S.; Greenberg, Michael J.; Lavine, Kory J. title: SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis date: 2021-02-26 journal: JACC Basic Transl Sci DOI: 10.1016/j.jacbts.2021.01.002 sha: cc082d24932d6942f7074db4d3ad98cf561fd21f doc_id: 975727 cord_uid: v7p13dh6 There is ongoing debate as to whether cardiac complications of coronavirus disease 2019 (COVID-19) result from myocardial viral infection or are secondary to systemic inflammation and/or thrombosis. We provide evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are susceptible to severe acute respiratory syndrome coronavirus 2. We establish an engineered heart tissue model of COVID-19 myocardial pathology, define mechanisms of viral pathogenesis, and demonstrate that cardiomyocyte severe acute respiratory syndrome coronavirus 2 infection results in contractile deficits, cytokine production, sarcomere disassembly, and cell death. These findings implicate direct infection of cardiomyocytes in the pathogenesis of COVID-19 myocardial pathology and provides a model system to study this emerging disease. There is ongoing debate as to whether cardiac complications of coronavirus disease 2019 (COVID-19) result from myocardial viral infection or are secondary to systemic inflammation and/or thrombosis. We provide evidence that cardiomyocytes are infected in patients with COVID-19 myocarditis and are susceptible to severe acute respiratory syndrome coronavirus 2. We establish an engineered heart tissue model of COVID-19 myocardial pathology, define mechanisms of viral pathogenesis, and demonstrate that cardiomyocyte severe acute respiratory syndrome coronavirus 2 infection results in contractile deficits, cytokine production, sarcomere disassembly, and cell death. These findings implicate direct infection of cardiomyocytes in the pathogenesis of COVID-19 myocardial pathology and provides a model system to study this emerging disease. We used human myocardial specimens and devised an engineered heart tissue (EHT) model of Continued on the next page Consistent with prior reports, we detected ACE2 mRNA expression in the human heart across the spectrum of age increasing in heart failure (19, 20) . (Figures 5F and 5G) . Potential effects of coronaviruses on the cardiovascular system: a review Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China COVID-19 and Cardiac Arrhythmias Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection Elevated troponin in patients with coronavirus disease 2019: possible mechanisms Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus A single human keratin 18 gene is expressed in diverse epithelial cells of transgenic mice An Infectious cDNA clone of SARS-CoV-2 Diagnosis of myocardial infarction at autopsy: AECVP reappraisal in the light of the current clinical classification Early markers for myocardial ischemia and sudden cardiac death Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2 Myocytespecific upregulation of ACE2 in cardiovascular disease: implications for SARS-CoV-2-mediated myocarditis Ultrastructural characterization of SARS coronavirus Electron microscopy of SARS-CoV-2: a challenging task The architecture of SARS-CoV-2 transcriptome Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease Proteolytic activation of the SARScoronavirus spike protein: cutting enzymes at the cutting edge of antiviral research A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells Furin cleavage site is key to SARS-CoV-2 pathogenesis Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin TBK1, a central kinase in innate immune sensing of nucleic acids and beyond Immune sensing mechanisms that discriminate self from altered self and foreign nucleic acids Myocardial localization of coronavirus in COVID-19 cardiogenic shock Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes SARS-CoV-2 productively infects human gut enterocytes Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids